Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial

OBJECTIVES: The COVID-19 pandemic has revealed a severe need for effective antiviral treatment. The objectives of this study were to assess if preemptive treatment with amantadine for COVID-19 in non-hospitalized persons ≥40 years or adults with comorbidities was able to prevent disease progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Weis, Nina, Bollerup, Signe, Sund, Jon Dissing, Glamann, Jakob Borg, Vinten, Caroline, Jensen, Louise Riger, Sejling, Christoffer, Kledal, Thomas Nitschke, Rosenkilde, Mette Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284620/
https://www.ncbi.nlm.nih.gov/pubmed/37353078
http://dx.doi.org/10.1016/j.cmi.2023.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284620/
https://www.ncbi.nlm.nih.gov/pubmed/37353078
http://dx.doi.org/10.1016/j.cmi.2023.06.023

Ejemplares similares